Cargando…
SPR-based fragment screening with neurotensin receptor 1 generates novel small molecule ligands
The neurotensin receptor 1 represents an important drug target involved in various diseases of the central nervous system. So far, the full exploitation of potential therapeutic activities has been compromised by the lack of compounds with favorable physicochemical and pharmacokinetic properties whi...
Autores principales: | Huber, Sylwia, Casagrande, Fabio, Hug, Melanie N., Wang, Lisha, Heine, Philipp, Kummer, Lutz, Plückthun, Andreas, Hennig, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433701/ https://www.ncbi.nlm.nih.gov/pubmed/28510609 http://dx.doi.org/10.1371/journal.pone.0175842 |
Ejemplares similares
-
Complexes of the neurotensin receptor 1 with small-molecule ligands reveal structural determinants of full, partial, and inverse agonism
por: Deluigi, Mattia, et al.
Publicado: (2021) -
Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands
por: Schaab, Carolin, et al.
Publicado: (2014) -
Probing the Conformation States of Neurotensin Receptor 1 Variants by NMR Site‐Directed Methyl Labeling
por: Goba, Inguna, et al.
Publicado: (2020) -
Small molecule AX-024 reduces T cell proliferation independently of CD3ϵ/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain
por: Richter, Kirsten, et al.
Publicado: (2020) -
Imaging Neurotensin Receptor in Prostate Cancer With (64)Cu-Labeled Neurotensin Analogs
por: Deng, Huaifu, et al.
Publicado: (2017)